New NHS Cream Restores Skin Color for Vitiligo Patients
The NHS introduces ruxolitinib, a new ‘life-changing’ cream for vitiligo, offering skin repigmentation to 100,000 people aged 12+. It’s the first approved treatment to restore lost skin colour.
The NHS introduces ruxolitinib, a new ‘life-changing’ cream for vitiligo, offering skin repigmentation to 100,000 people aged 12+. It’s the first approved treatment to restore lost skin colour.
The NHS expands its routine childhood vaccination program to include chickenpox (varicella) from today, protecting hundreds of thousands of children from serious illness.
The NHS now screens all newborns for Hereditary Tyrosinaemia Type 1 (HT1), a rare, life-threatening metabolic disorder. Early detection prevents severe complications and improves outcomes.